(TRIN) Trinity Capital - Ratings and Ratios
Loans, Financing, Investments
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 13.41% |
| Yield on Cost 5y | 25.76% |
| Yield CAGR 5y | 17.42% |
| Payout Consistency | 95.6% |
| Payout Ratio | 95.8% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 19.6% |
| Value at Risk 5%th | 30.6% |
| Relative Tail Risk | -5.30% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.75 |
| Alpha | 10.55 |
| CAGR/Max DD | 1.52 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.380 |
| Beta | 0.566 |
| Beta Downside | 0.665 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.72% |
| Mean DD | 4.33% |
| Median DD | 3.43% |
Description: TRIN Trinity Capital November 17, 2025
Trinity Capital Inc. (NASDAQ: TRIN) is a publicly traded business development company (BDC) that originated in 2019 and operates out of Phoenix, Arizona, with a satellite office in San Diego. The firm focuses on term-loan and equipment-financing structures, as well as private-equity-adjacent investments across sectors such as technology, life sciences, warehouse assets, and sponsor-finance deals, aiming to deliver stable, recurring cash flows to its shareholders by tapping the private credit market.
Key operating metrics (as of the latest 10-K) show an asset base of roughly $1.2 billion, a weighted-average portfolio yield near 8.5 % and a distribution rate that has averaged 7.8 % over the past 12 months. The BDC’s credit exposure is heavily weighted toward senior secured loans (≈ 55 % of assets) with an average loan-to-value of 68 %, reflecting a conservative risk profile. Macro-driven factors that influence performance include the Federal Reserve’s interest-rate trajectory-higher rates can boost loan yields but also pressure borrower cash-flows-and the ongoing demand for technology-related equipment financing, which has grown at a compound annual rate of ~ 12 % in the U.S. private-credit sector.
For a deeper, data-driven look at TRIN’s valuation dynamics and scenario analysis, you may find ValueRay’s analytical dashboards useful as a next step in your research.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (142.0m TTM) > 0 and > 6% of Revenue (6% = 15.9m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 31.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -0.95% (prev -2.00%; Δ 1.05pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 86.5m <= Net Income 142.0m (YES >=105%, WARN >=100%) |
| Net Debt (-9.47m) to EBITDA (162.9m) ratio: -0.06 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.92 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (71.5m) change vs 12m ago 22.43% (target <= -2.0% for YES) |
| Gross Margin 78.65% (prev 72.76%; Δ 5.89pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 13.33% (prev 11.29%; Δ 2.05pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.86 (EBITDA TTM 162.9m / Interest Expense TTM 75.7m) >= 6 (WARN >= 3) |
Altman Z'' 0.17
| (A) -0.00 = (Total Current Assets 28.9m - Total Current Liabilities 31.5m) / Total Assets 2.25b |
| (B) -0.01 = Retained Earnings (Balance) -16.9m / Total Assets 2.25b |
| (C) 0.03 = EBIT TTM 64.9m / Avg Total Assets 1.99b |
| (D) -0.01 = Book Value of Equity -16.8m / Total Liabilities 1.25b |
| Total Rating: 0.17 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 67.71
| 1. Piotroski 4.0pt |
| 2. FCF Yield 4.26% |
| 3. FCF Margin 32.38% |
| 4. Debt/Equity 0.88 |
| 5. Debt/Ebitda -0.06 |
| 6. ROIC - WACC (= -2.28)% |
| 7. RoE 15.87% |
| 8. Rev. Trend 67.19% |
| 9. EPS Trend 18.94% |
What is the price of TRIN shares?
Over the past week, the price has changed by -0.26%, over one month by +4.75%, over three months by -2.33% and over the past year by +20.76%.
Is TRIN a buy, sell or hold?
- Strong Buy: 6
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the TRIN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.5 | 8.5% |
| Analysts Target Price | 16.5 | 8.5% |
| ValueRay Target Price | 21 | 38.3% |
TRIN Fundamental Data Overview December 16, 2025
P/E Trailing = 6.8688
P/E Forward = 7.2993
P/S = 4.2825
P/B = 1.1509
P/EG = 5.256
Beta = 0.605
Revenue TTM = 265.5m USD
EBIT TTM = 64.9m USD
EBITDA TTM = 162.9m USD
Long Term Debt = unknown (none)
Short Term Debt = 1.31m USD (from shortTermDebt, last fiscal year)
Debt = 877.7m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -9.47m USD (from netDebt column, last quarter)
Enterprise Value = 2.02b USD (1.15b + Debt 877.7m - CCE 9.47m)
Interest Coverage Ratio = 0.86 (Ebit TTM 64.9m / Interest Expense TTM 75.7m)
FCF Yield = 4.26% (FCF TTM 86.0m / Enterprise Value 2.02b)
FCF Margin = 32.38% (FCF TTM 86.0m / Revenue TTM 265.5m)
Net Margin = 53.49% (Net Income TTM 142.0m / Revenue TTM 265.5m)
Gross Margin = 78.65% ((Revenue TTM 265.5m - Cost of Revenue TTM 56.7m) / Revenue TTM)
Gross Margin QoQ = 68.32% (prev 76.29%)
Tobins Q-Ratio = 0.90 (Enterprise Value 2.02b / Total Assets 2.25b)
Interest Expense / Debt = 2.39% (Interest Expense 21.0m / Debt 877.7m)
Taxrate = 2.28% (644.0k / 28.3m)
NOPAT = 63.4m (EBIT 64.9m * (1 - 2.28%))
Current Ratio = 0.92 (Total Current Assets 28.9m / Total Current Liabilities 31.5m)
Debt / Equity = 0.88 (Debt 877.7m / totalStockholderEquity, last quarter 998.3m)
Debt / EBITDA = -0.06 (Net Debt -9.47m / EBITDA 162.9m)
Debt / FCF = -0.11 (Net Debt -9.47m / FCF TTM 86.0m)
Total Stockholder Equity = 894.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.32% (Net Income 142.0m / Total Assets 2.25b)
RoE = 15.87% (Net Income TTM 142.0m / Total Stockholder Equity 894.6m)
RoCE = 2.93% (EBIT 64.9m / Capital Employed (Total Assets 2.25b - Current Liab 31.5m))
RoIC = 3.32% (NOPAT 63.4m / Invested Capital 1.91b)
WACC = 5.60% (E(1.15b)/V(2.03b) * Re(8.10%) + D(877.7m)/V(2.03b) * Rd(2.39%) * (1-Tc(0.02)))
Discount Rate = 8.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 21.89%
[DCF Debug] Terminal Value 78.12% ; FCFE base≈86.0m ; Y1≈86.1m ; Y5≈91.5m
Fair Price DCF = 21.18 (DCF Value 1.60b / Shares Outstanding 75.7m; 5y FCF grow -0.45% → 3.0% )
EPS Correlation: 18.94 | EPS CAGR: 8.72% | SUE: -0.04 | # QB: 0
Revenue Correlation: 67.19 | Revenue CAGR: -0.76% | SUE: -1.11 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.52 | Chg30d=-0.003 | Revisions Net=-1 | Analysts=10
EPS next Year (2026-12-31): EPS=2.09 | Chg30d=-0.006 | Revisions Net=-1 | Growth EPS=+0.3% | Growth Revenue=+17.4%
Additional Sources for TRIN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle